| Order | October 28, 2024 | Fee Panel Order No. 40 Regarding Contingent Fee Fund Credits and Rebates to Walmart, Establishment of an Administrative Expense Account, and a Prudent Reserves Holdback |
| Order | October 25, 2024 | Fee Panel Order No. 39 Regarding Contingent Fee Fund Credits and Rebates to Walgreens, Establishment of an Administrative Expense Account, and a Prudent Reserves Holdback |
| Order | August 28, 2024 | Fee Panel Order No. 36-G Regarding Adjustments to Common Benefit Amount to be Paid by Walgreens |
| Order | August 7, 2024 | Fee Panel Order No. 36-D Regarding Adjustments to Common Benefit Amount to be Paid by Teva |
| Order | August 2, 2024 | Tribal Cost Fund Order |
| Order | August 2, 2024 | Fee Panel Order No. 36-C Regarding Adjustments to Common Benefit Amount to be Paid by Walmart |
| Order | August 2, 2024 | Fee Panel Order No. 36-A Regarding Adjustments to Common Benefit Amount to be Paid by Distributors |
| Order | July 26, 2024 | Fee Panel Order No. 34 Regarding Credits and Rebates to Teva, Establishment of an Administrative Expense Account, and a Prudent Reserves Holdback |
| Order | June 4, 2024 | Order Granting Motion of the Directors of the Tribal Abatement Fund Trust IV and the Tribal Abatement Fund Trust VI for an Order Waiving Annual Report Audit Requirements |
| Order | April 10, 2024 | Order to Establish Taft X Professionals Fee Fund and Endo Public Opioid Political Subdivision Costs and Fees Fund |
| Order | March 28, 2024 | Fee Panel Order No. 33 Regarding Eligibility of Rhode Island Subdivisions for Teva and Allergan Contingency Fee Funds |
| Order | February 7, 2024 | Fee Panel Order No. 30 Regarding Extending Application Deadline for Settling Pharmacies Contingency Fee Award |
| Order | January 23, 2024 | Fee Panel Order No. 29 Regarding Application Deadline for Settling Pharmacies Contingency Fee Awards |
| Order | January 3, 2024 | Order Granting PEC and TLC Motion to Confirm Fee Panel Determination of Common Benefit Awards for Tribal Work Concurrently and in Conjunction with Other Common Benefit Work |
| Order | December 18, 2023 | Fee Panel Order No. 28 Regarding Applications Received for Awards from the Teva/Allergan Contingency Fee Fund |
| Order | November 30, 2023 | Order to Establish Qualified Settlement Fund and Appoint Settlement Referee for Sandoz Settlement Agreement |
| Order | October 2, 2023 | Order Designating Special Master Pursuant to Global Tribal Opioid Settlement Agreements |
| Order | August 28, 2023 | Order to Show Cause Regarding the Motion to Dismiss at Docket No. 467 |
| Order | July 24, 2023 | Fee Panel Order No. 25 Regarding Back-Stop Funds in the State of Michigan |
| Order | July 6, 2023 | Order Regarding 7.5% Common Benefit Assessments |
| Order | June 29, 2023 | Fee Panel Order No. 23 Regarding Communication with Counsel and Third Parties |
| Order | June 27, 2023 | Order to Establish Qualified Settlement Funds, Appoint Panel of Common Benefit and Contingency Fee Fund Arbiters, Approve Fee Fund Allocation and Distribution Process, and Approve Common Benefit Cost Payment and Assessment |
| Order | June 27, 2023 | Order Regarding Recent Settlement Agreements |
| Order | June 26, 2023 | Order to Establish Qualified Settlement Fund, Appoint Panel of Common Benefit and Contingency Fee Fund Arbiters, Approve Fee Fund Allocation and Distribution Process, and Approve Common |
| Order | February 24, 2023 | Benefit Cost Payment and Assessment |
| Notice | February 24, 2023 | Notice to All Counsel Representing Commonwealth of Pennsylvania Parties of Their Eligibility to Apply for Reimbursement of Contingency Fees from the Pennsylvania Opioid Fee Fund Relating to the Settlements with the Distributor and J&J Defendants |
| Order | February 22, 2023 | Order to Establish Additional Qualified Settlement Funds |
| Order | February 21, 2023 | Order to Establish Qualified Settlement Funds and Appoint QSF Administrator |
| Order | January 25, 2023 | Order Regarding Master Stipulation of Dismissal of Claims Against Settling Defendants |
| Order | January 4, 2023 | Order Granting Settling Defendants’ Motion to Stay Further Briefing on Settling Defendants’ Motion to Dismiss Claims Filed by Non-Participating Georgia Subdivisions as Barred by Statute |
| Order | December 21, 2022 | Non-Document Order |
| Order | December 21, 2022 | Fee Panel Order No. 18 Regarding Rhode Island Attorney Fee Fund Payments to Distributors |
| Order | December 14, 2022 | Appeal Order |
| Order | December 14, 2022 | Appeal Order |
| Order | December 14, 2022 | Appeal Order |
| Order | December 13, 2022 | Fee Panel Order No. 17 Regarding Back-Stop Funds in the State of Georgia |
| Order | December 13, 2022 | Fee Panel Order No. 16 Regarding Back-Stop Funds in the State of Kentucky |
| Order | December 8, 2022 | Fee Panel Order No. 15 Regarding Back-Stop Funds in the State of New Mexico |
| Order | December 5, 2022 | Non-document Order granting Agreed Motion Modifying Track 8 Deadlines as to CVS, Kroger, Walgreens, and Walmart |
| Order | December 2, 2022 | Stipulated Order Entering Stay and Modifying Track 11 Deadlines |
| Order | November 28, 2022 | Non-Document Order |
| Order | November 20, 2022 | Fee Panel Order No. 12 Regarding Sharing of Information with State Attorneys General |
| Order | August 17, 2022 | Injunction Order |
| Order | August 17, 2022 | Abatement Order |
| Order | August 12, 2022 | Plaintiffs’ Second Notice of Supplemental Authority |
| Order | August 12, 2022 | Findings of Fact and Conclusions of Law re Walgreens |
| Order | August 3, 2022 | Findings of Fact and Conclusions of Law on Order Denying Pharmacy Defendants’ Motions to Dismiss Complaints and Amended Complaints |
| Order | June 17, 2022 | Order Appointing the Fee Panel to Allocate and Disburse Attorney Fees Provided for in State Back-Stop Agreements |
| Order | June 17, 2022 | Fee Panel Order No. 8 Regarding Fee Application Questions |
| Order | June 13, 2022 | Fee Panel Order No. 7 |
| 6/8 Order 5/9 Order | June 8, 2022 (and May 9, 2022 predecessor) | Ongoing Common Benefit Order; Order Clarifying Ongoing Common Benefit Order |
| Order | May 27, 2022 | Fee Panel Order No. 4 |
| Order | May 13, 2022 | Fee Panel Order No. 3: Contingency Fee Awards |
| 5/9 Order 6/8 Order | May 9, 2022 (and June 8, 2022 successor order) | Ongoing Common Benefit Order; Order Clarifying Ongoing Common Benefit Order |
| Order | April 19, 2022 | Fee Panel Order No. 1 |
| Order | April 1, 2022 | Order Establishing Application Protocols for Reimbursement of Common Benefit Attorneys’ Fees Under the Janssen and Distributors Settlement Agreements |
| Order | March 23, 2022 | Non-Document Order |
| Order | March 8, 2022 | Order Approving Attorney Fee Fund Start-Up Matters |
| Order | February 25, 2022 | Order Clarifying the “CMO Effective Date” for Cases of Non-Participating Subdivisions |
| Order | February 25, 2022 | Order Appointing Fee Committee |
| Order | December 16, 2021 | Decision and Order on Appeal |
| Order | October 18, 2021 | Order Regarding McKinsey’s Motion to Vacate |
| Order | October 15, 2021 | Order Regarding Fee Panel, Fund Administrator, and Assistants |
| Order | August 12, 2021 | Order to Establish Qualified Settlement Fund, Appoint Panel Of Common Benefit and Contingency Fee Fund Arbiters, Approve Fee Fund Allocation And Distribution Process, and Approve Common Benefit Cost Payment and Assessment |
| Order | August 6, 2021 | Contingency Cap Order |